Stock Comparison
JNJ vs PFE
Johnson & Johnson and Pfizer Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$613.02B
$138.44B
P/E (TTM)
29.5
18.5
Forward P/E
22.0
8.2
Price/Sales
6.4
2.2
Price/Book
7.6
1.5
EV/EBITDA
19.2
11.0
Dividend Yield
2.12%
7.27%
Profitability
Net Margin
21.80%
11.80%
Operating Margin
27.40%
31.60%
Return on Equity
26.40%
8.31%
Return on Assets
8.42%
5.69%
Growth (YoY)
Revenue Growth
9.90%
5.40%
Earnings Growth
-52.90%
-10.10%
Price & Risk
Beta
0.3
0.3
52-Week High
$255.11
$28.28
52-Week Low
$147.81
$21.97
Analyst Target
$257.32
$29.15
Compare JNJ and PFE your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.